ObsEva Stock Forecast, Price & News

ObsEva (NASDAQ:OBSV) Frequently Asked Questions

Is ObsEva a buy right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for ObsEva in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" ObsEva stock.
View analyst ratings for ObsEva or view top-rated stocks.

How has ObsEva's stock been impacted by Coronavirus (COVID-19)?

ObsEva's stock was trading at $2.57 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, OBSV stock has decreased by 34.2% and is now trading at $1.69.
View which stocks have been most impacted by COVID-19.

When is ObsEva's next earnings date?

ObsEva is scheduled to release its next quarterly earnings announcement on Friday, March 4th 2022.
View our earnings forecast for ObsEva.

How were ObsEva's earnings last quarter?

ObsEva SA (NASDAQ:OBSV) issued its quarterly earnings results on Thursday, November, 4th. The company reported $0.01 EPS for the quarter, beating analysts' consensus estimates of ($0.22) by $0.23.
View ObsEva's earnings history.

What price target have analysts set for OBSV?

2 analysts have issued 12-month price targets for ObsEva's stock. Their forecasts range from $15.00 to $21.00. On average, they expect ObsEva's share price to reach $18.00 in the next twelve months. This suggests a possible upside of 965.1% from the stock's current price.
View analysts' price targets for ObsEva or view top-rated stocks among Wall Street analysts.

Who are ObsEva's key executives?

ObsEva's management team includes the following people:

• Brian O'Callaghan, Chief Executive Officer & Director
• David Renas, Chief Financial Officer
• Jean-Pierre Gotteland, Chief Scientific Officer, Head-R&D
• Elizabeth Ijeoma Onyemelukwe Garner, Chief Medical Officer
• Elke Bestel, VP, Head-Drug Safety & Pharmacovigilance

Who are some of ObsEva's key competitors?

Some companies that are related to ObsEva include Fulcrum Therapeutics (FULC), Zymeworks (ZYME), Mirum Pharmaceuticals (MIRM), Inventiva (IVA), Albireo Pharma (ALBO), Relmada Therapeutics (RLMD), LianBio (LIAN), Chimerix (CMRX), Tyra Biosciences (TYRA), Phathom Pharmaceuticals (PHAT), SIGA Technologies (SIGA), Deciphera Pharmaceuticals (DCPH), Lexicon Pharmaceuticals (LXRX), 2seventy bio (TSVT) and BioXcel Therapeutics (BTAI).
View all of OBSV's competitors.

What other stocks do shareholders of ObsEva own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ObsEva investors own include Sorrento Therapeutics (SRNE), SCYNEXIS (SCYX), Dynavax Technologies (DVAX), Matinas BioPharma (MTNB), Trevena (TRVN), Zosano Pharma (ZSAN), Vaxart (VXRT), VBI Vaccines (VBIV), Bionano Genomics (BNGO) and ADMA Biologics (ADMA).

When did ObsEva IPO?

(OBSV) raised $98 million in an initial public offering on Thursday, January 26th 2017. The company issued 6,500,000 shares at a price of $14.00-$16.00 per share. Credit Suisse, Jefferies and Leerink Partners served as the underwriters for the IPO.

What is ObsEva's stock symbol?

ObsEva trades on the NASDAQ under the ticker symbol "OBSV."

Who are ObsEva's major shareholders?

ObsEva's stock is owned by many different institutional and retail investors. Top institutional shareholders include Wedbush Securities Inc. (0.04%).

Which major investors are selling ObsEva stock?

OBSV stock was sold by a variety of institutional investors in the last quarter, including Wedbush Securities Inc..

How do I buy shares of ObsEva?

Shares of OBSV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ObsEva's stock price today?

One share of OBSV stock can currently be purchased for approximately $1.69.

How much money does ObsEva make?

ObsEva has a market capitalization of $131.77 million and generates $20 thousand in revenue each year. The company earns $-82.97 million in net income (profit) each year or ($0.85) on an earnings per share basis.

How many employees does ObsEva have?

ObsEva employs 45 workers across the globe.

What is ObsEva's official website?

The official website for ObsEva is www.obseva.com.

Where are ObsEva's headquarters?

ObsEva is headquartered at Chemin des Aulx 12 Plan-les-Ouates, Geneva V8, 1228.

How can I contact ObsEva?

ObsEva's mailing address is Chemin des Aulx 12 Plan-les-Ouates, Geneva V8, 1228. The company can be reached via phone at (122) 552-3840 or via email at [email protected].